Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4528245

O=C(O)C(F)(F)F.c1ccc2c(N3CCNCC3)cccc2c1

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 9/20 0.72
HTR5A P47898 2/20 0.72
NCF1 P14598 2/20 0.72
HTR3E A5X5Y0 1/20 0.72
HTR3B O95264 1/20 0.72
CYP1A2 P05177 1/20 0.72
HTR1A P08908 1/20 0.72
CYP2D6 P10635 1/20 0.72
TSHR P16473 1/20 0.72
NFKB1 P19838 1/20 0.72
HTR1D P28221 1/20 0.72
HTR1B P28222 1/20 0.72
HTR2A P28223 1/20 0.72
HTR7 P34969 1/20 0.72
MTOR P42345 1/20 0.72
HTR3A P46098 1/20 0.72
HTR3D Q70Z44 1/20 0.72
HTR3C Q8WXA8 1/20 0.72
HSD17B10 Q99714 1/20 0.72
SIGMAR1 Q99720 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5254026 0.86 HTR5A (0.59) HTR6HTR5ANCF1HTR3EHTR3B
SCHEMBL29385724 0.85 HTR6 (1.00) HTR6HTR5ANCF1HTR3EHTR3B
SCHEMBL3166780 0.85 HTR6 (1.00) HTR6HTR5ANCF1HTR3EHTR3B
SCHEMBL240244 0.85 HTR6 (1.00) HTR6HTR5ANCF1HTR3EHTR3B
Hydrochloric Acid SCHEMBL25379293 0.83 LMNA (1.00) HTR6HTR5ANCF1HTR3EHTR3B
Hydrochloric Acid SCHEMBL27664894 0.83 LMNA (1.00) HTR6HTR5ANCF1HTR3EHTR3B
Hydrochloric Acid SCHEMBL466870 0.83 LMNA (1.00) HTR6HTR5ANCF1HTR3EHTR3B
Trifluoroacetic Acid SCHEMBL30839779 0.80 BACE1 (0.46) HTR6HTR5ANCF1HTR3EHTR3B
Trifluoroacetic Acid SCHEMBL30839757 0.80 ADRB1 (0.74) HTR6
SCHEMBL7719591 0.79 HTR6 (0.87) HTR6HTR5ANCF1HTR3EHTR3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090238761-A1 Novel Aryl Piperazine Derivatives With Medical Utility UNIVERSITA DEGLI STUDI DI SIENA (IT) 2009-09-24 US disclosed
CN-101137645-A Arylpiperazine derivatives for the treatment of neuropsychiatric disorders UNIV SIENA (IT) 2008-03-05 CN disclosed
EP-1836192-A2 ARYL PIPERAZINE DERIVATIVES FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS Universita' Degli Studi di Siena (IT) 2007-09-26 EP disclosed
WO-2006072608-A2 ARYL PIPERAZINE DERIVATIVES FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS UNIVERSITÁ DEGLI STUDI DI SIENA (IT) 2006-07-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090238761-A1 Novel Aryl Piperazine Derivatives With Medical Utility HTR2C, HTR2A, DRD2 HTR6 16/4885HTR5A 8/4885NCF1 4546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.